Published in:
01-03-2015 | Letter to the Editor
Response to commentary by Champ and Klement
Is a ketogenic diet the solution for the hyperglycemia problem in glioblastoma therapy?
Authors:
Arnulf Mayer, Peter Vaupel, Hans-Garlich Struss, Alf Giese, Marcus Stockinger, Heinz Schmidberger
Published in:
Strahlentherapie und Onkologie
|
Issue 3/2015
Login to get access
Excerpt
We thank Drs. Champ and Klement for their interesting and partly provocative comments, and Strahlentherapie und Onkologie for the opportunity to respond to them. Like a considerable number of physicians, biologists, nonmedical practitioners (“Heilpraktiker”), and patients, they enthusiastically advocate a ketogenic diet as a supportive and possibly even therapeutic measure for cancer patients, in particular for patients with glioblastoma multiforme (GBM). In the last sentence of their letter they even conclude that “the burden of proofing any clinically harmful effects” of ketogenic diets “rests upon those who warn against their usage.” This is a bold statement, and we have to ask the question as to whether the arguments in favor of ketogenic diets live up to the criteria of scientific, evidence-based medicine. …
